• Core poultry sales grew for the Ingham’s Group in FY22, but the impact of Omicron was too big for the company to recover financially by the end of financial year. (Source image: Ingham's Group)
    Core poultry sales grew for the Ingham’s Group in FY22, but the impact of Omicron was too big for the company to recover financially by the end of financial year. (Source image: Ingham's Group)
Close×

Core poultry sales grew for the Ingham’s Group in FY22, but the impact of Omicron was too big for the company to recover financially by the end of financial year.

Statutory Earnings Before Interest, Tax, Depreciation, and Amortisation (EBITDA) was down 16.6 per cent on PCP to $370.4 million, while Statutory Net Profits After Tax (NPAT) was down 57.9 per cent to $35.1 million.

Snapshot

  • Group Core Poultry Volume: 465.6 kt, up 4.2%;
  • Statutory EBITDA: $370.4m, down 16.6%;
  • Statutory NPAT: $35.1m, down 57.9%; and
  • Net Debt: $267.3m, up 11.3%.

“Given the major operational challenges in the third quarter due to Omicron, it has not been possible to recover the financial results shortfall for that quarter, hence the full year results were significantly lower that PCP,” the company said.

Cash flow from operations was $372.5 million, down 17.5 per cent versus PCP due to “significantly” lower trading results.

The company had a major channel mix shift to Wholesale, which cause a reduction in production line value-add products in H2 and channel oversupply and lower pricing in Q3,

Ingham’s said the shift to Wholesale was industry wide due to SKUs during Omicron being temporarily rationalised, which impacted products in the Retail chain. Margins in the Wholesale channel have “significantly improved”, it said.

In Australia, revenue increased 1.7 per cent on PCP, driven by 5.2 per cent growth in core poultry volume and a 3.5 per cent drop in net selling prices stemming from the channel mix shift from Retail to Wholesale.

The cost of sales increased 5.7 per cent with major cost inflation across a broad variety of inputs, particularly for feed, ingredients and transport costs. Feed costs increased by $45.4 million.

Ingham’s said the recovery it started to see in Q4 is continuing, but there are still “headwinds” in H1FY23, including the return to normal performance levels of farming and operations, supply chain delays, on-going absenteeism, inflation and price increases.

Packaging News

Ego Pharmaceuticals has unveiled a bold new chapter in its commitment to local manufacturing, announcing a $156 million, decade-long investment to expand its Victorian operations.

After an extended period of grace for brands whose packaging carried the REDcycle and Return to Store labelling, the deadline is here for complete removal from soft plastic packaging in Australia.

The 2025 PKN Women in Packaging Awards, presented in Sydney today, have once again shone a powerful spotlight on the exceptional women driving progress, innovation, and impact across every corner of the packaging value chain.